Literature DB >> 4563533

A double-blind crossover trial comparing a new antirheumatic agent alclofenac with phenylbutazone in chronic rheumatic disorders.

M Anylward, D B Davies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4563533

Source DB:  PubMed          Journal:  Br J Clin Pract        ISSN： 0007-0947


× No keyword cloud information.
  4 in total

1.  A double blind trial to assess the value of alclofenac compared with phenylbutazone in the management of rheumatoid arthritis.

Authors:  M A Chamberlain; V Wright
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

2.  Alclofenac: a review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

3.  Vasculitis with alclofenac therapy.

Authors:  R A Billings; H C Burry; F S Emaslie; G D Kerr
Journal:  Br Med J       Date:  1974-11-02

4.  Studies on 4-allyloxy-3 chlorophenylacetic acid (Alcofenac). A double-blind comparison of Alcofenac and aspirin in rheumatoid arthritis, and effects of therapy on serum immunoglobulins and rheumatoid factor.

Authors:  M Aylward; R J Parker; J Maddock
Journal:  Ann Rheum Dis       Date:  1974-05       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.